NCT06801392 Left Atrial Posterior Wall and Mitral Isthmus PF Ablation in Non-Paroxysmal AF Patients
| NCT ID | NCT06801392 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Charles University, Czech Republic |
| Condition | Atrial Fibrillation (AF) |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2025-01-01 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
An observational study evaluating efficacy and safety of the Varipulse catheter in pulsed-field ablation of atrial fibrillation
Eligibility Criteria
Inclusion Criteria: 1. non-paroxysmal atrial fibrillation 2. an indication for catheter ablation according current guidelines 3. willingness to sign informed content. Exclusion Criteria: 1. hematological disorders that can be associated with spontaneous hemolysis 2. chronic kidney disease stage 3 or worse 3. previous left atrial ablation (either using pulsed-field or radiofrequency energy)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06801392 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Atrial Fibrillation (AF). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06801392 currently recruiting?
Yes, NCT06801392 is actively recruiting participants. Contact the research team at pavel.osmancik@gmail.com for enrollment information.
Where is the NCT06801392 trial being conducted?
This trial is being conducted at Prague, Czechia.
Who is sponsoring the NCT06801392 clinical trial?
NCT06801392 is sponsored by Charles University, Czech Republic. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.